GPTHEALTH · Healthcare · Medical Care Facilities
Composite scorecard: 32/100 — Quality 45 · Valuation 15 · Momentum 31
| Share price | ₹149.05 |
| Market cap | ₹1,297 Cr |
| P/E ratio | 30.8 |
| P/B ratio | 4.8 |
| ROE | 21.9% |
| ROCE | 16.2% |
| Dividend yield | 1.90% |
| Book value | ₹32.92 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹472 Cr | ₹42 Cr | 12.4% |
| 2025 | ₹406 Cr | ₹50 Cr | 16.5% |
| 2024 | ₹400 Cr | ₹48 Cr | 18.0% |
| 2023 | ₹360 Cr | ₹39 Cr | 16.5% |
| 2022 | ₹337 Cr | ₹42 Cr | 22.0% |
GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurology; neurosurgery; pediatrics; neonatology; robotic-assisted surgery; bariatric surgery; hematology; psychology; dermatology; and ENT services. It also operates clinics and pharmacies; provide